These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 2567367)

  • 41. [Use of beta-adrenergic blocking agents in acute myocardial infarction (author's transl)].
    Wirtzfeld A; Klein G; Himmler FC; Schmidt G
    Herz; 1981 Apr; 6(2):73-83. PubMed ID: 6112196
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [New data on risks and benefits: beta blockers despite asthma? (interview by Dr. Beate Schumacher)].
    Gillissen A
    MMW Fortschr Med; 2011 Jun; 153(24-25):6. PubMed ID: 21721166
    [No Abstract]   [Full Text] [Related]  

  • 43. [Efficiency of ACE inhibitors, beta adrenoblocker and antihypoxant in the phase of stationary rehabilitation of patients with myocardial infarction working in environmentally unfriendly conditions].
    Agaev MM
    Klin Med (Mosk); 2010; 88(1):58-62. PubMed ID: 20369615
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Use of inhibitors of the angiotensin-converting enzyme and the beta-adrenoblocker metoprolol combined in treatment of chronic cardiac insufficiency].
    Voronkov LG; Serdiuk TE; Riabenko DV
    Lik Sprava; 2000; (7-8):77-80. PubMed ID: 16786657
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Use of beta-adrenoblockers in the treatment of acute myocardial infarct patients].
    Ol'binskaia LI; Maglakelidze TA; Cherniak MS
    Klin Med (Mosk); 1987 Feb; 65(2):35-8. PubMed ID: 2883341
    [No Abstract]   [Full Text] [Related]  

  • 46. In-vitro and in-vivo effects of theophylline and beta 2-adrenostimulants in combination.
    Svedmyr N; Svedmyr K
    Eur J Respir Dis Suppl; 1980; 109():83-91. PubMed ID: 6108228
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Sympathomimetic inefficiency in restoring contractility in the acute or chronic beta-blocker-treated ischaemic heart: comparison with a new agent.
    Mattera GG; Vanoli E; Gagnol JP; Loi FM; Borsini F; Carminati P
    Eur J Heart Fail; 2008 Oct; 10(10):990-6. PubMed ID: 18693136
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [The effects of combined beta(1) adrenergic receptor antagonist and beta(2) adrenergic receptor agonist therapy on cardiac function and myocardial apoptosis in heart failure rats].
    Li WM; Gan RT; Wang X; Wu S; Shen JX; Xiu CH
    Zhonghua Xin Xue Guan Bing Za Zhi; 2007 Jul; 35(7):615-9. PubMed ID: 17961425
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Rationale, design and organization of the Second Chinese Cardiac Study (CCS-2): a randomized trial of clopidogrel plus aspirin, and of metoprolol, among patients with suspected acute myocardial infarction. Second Chinese Cardiac Study (CCS-2) Collaborative Group.
    Second Chinese Cardiac Study (CCS-2) Collaborative Group
    J Cardiovasc Risk; 2000 Dec; 7(6):435-41. PubMed ID: 11189013
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Hemodynamic and respiratory effects of enoximone in acute respiratory insufficiency of chronic obstructive bronchopneumopathy].
    Lefebvre MC; Durocher A; Saulnier F; Wattel F
    Therapie; 1990; 45(5):447-52. PubMed ID: 2148031
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Relation between myocardial beta-adrenoceptor density and hemodynamic and neurohumoral changes in a rat model of chronic myocardial infarction: effects of ibopamine and captopril.
    van Veldhuisen DJ; Brodde OE; van Gilst WH; Schulze C; Hegeman H; Anthonio RL; Scholtens E; de Graeff PA; Wesseling H; Lie KI
    Cardiovasc Res; 1995 Sep; 30(3):386-93. PubMed ID: 7585830
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Indications for beta-adrenergic drugs in the treatment of respiratory insufficiency.
    Brouet G; Ruff F
    Minerva Med; 1976 Mar; 67(15):926-9. PubMed ID: 4749
    [No Abstract]   [Full Text] [Related]  

  • 53. Use of beta-blockers during and after myocardial infarction.
    Aronow WS
    Compr Ther; 1998; 24(6-7):327-31. PubMed ID: 9669097
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Evaluation using dynamic ECG of the effects of reproterol (a new beta-2 adrenergic receptor agonist) on the heart conduction system].
    Citone C; Carelli M; Di Marcotullio G; Tubaro M; Milazzotto F
    Clin Ter; 1984 Sep; 110(5):429-36. PubMed ID: 6149836
    [No Abstract]   [Full Text] [Related]  

  • 55. [Postinfarction remodeling of the left atrium and left ventricle: effects of long-term treatment with beta adrenergic blockers and angiotensin converting enzyme inhibitors].
    Mazur NA; Vikent'ev VV
    Ter Arkh; 2001; 73(2):29-32. PubMed ID: 11338850
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Muscular mechanisms of lowering of physical working capacity in chronic heart failure and action of beta-adrenoblockers].
    Syrkin AL; Poltavskaia MG; Molchanova IV; Churganova LIu; Chaplygin AV
    Kardiologiia; 2005; 45(10):31-8. PubMed ID: 16234766
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Dynamics of postinfarction left ventricular remodeling during long term use of perindopril, amiodarone, and beta-adrenoblockers].
    Kanorskiĭ SG; Staritskiĭ AG; Bozhko AA
    Kardiologiia; 2005; 45(3):31-5. PubMed ID: 15821705
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Replacing β agonists with antimuscarinic drugs in patients with COPD.
    Wolstenholme RJ
    BMJ; 2014 Jan; 348():g1108. PubMed ID: 24477010
    [No Abstract]   [Full Text] [Related]  

  • 59. Beta-adrenoceptor agonists and obstructive airways disease.
    Ind PW
    Lancet; 1982 Aug; 2(8294):388. PubMed ID: 6124789
    [No Abstract]   [Full Text] [Related]  

  • 60. [Beta-receptor blockaders and chronic obstructive respiratory tract diseases].
    Lohmann FW
    Dtsch Med Wochenschr; 1994 Mar; 119(11):404; author reply 405. PubMed ID: 7907544
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.